Etanercept, a well-established tumor necrosis factor (TNF) inhibitor, is widely used in treating autoimmune diseases such as rheumatoid arthritis and psoriasis. The research-grade biosimilar of Etanercept offers a cost-effective and
Etanercept, a well-established tumor necrosis factor (TNF) inhibitor, is widely used in treating autoimmune diseases such as rheumatoid arthritis and psoriasis. The research-grade biosimilar of Etanercept offers a cost-effective and